GOLDMAN SACHS GROUP INC - MINK THERAPEUTICS INC ownership

MINK THERAPEUTICS INC's ticker is and the CUSIP is 603693102. A total of 46 filers reported holding MINK THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of MINK THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$16,669
+17.4%
17,561
+12.3%
0.00%
Q1 2024$14,199
-33.8%
15,632
-22.1%
0.00%
Q4 2023$21,461
+12.7%
20,057
+15.9%
0.00%
Q3 2023$19,043
-46.7%
17,312
+1.8%
0.00%
Q2 2023$35,72917,0140.00%
Other shareholders
MINK THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Longbow Finance SA 166,666$158,1990.02%
Covestor Ltd 1,055$10.00%
Qube Research & Technologies Ltd 1,941$1,8420.00%
CHILTON CAPITAL MANAGEMENT LLC 309$2940.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 1,548$1,4690.00%
Allworth Financial LP 2$20.00%
Camelot Portfolios, LLC 205$1950.00%
BANK OF AMERICA CORP /DE/ 2,038$1,9340.00%
WELLS FARGO & COMPANY/MN 10,860$10,3080.00%
NORTHERN TRUST CORP 11,073$10,5110.00%
View complete list of MINK THERAPEUTICS INC shareholders